Development of novel and stable glucagon formulations for closed loop systems

Ended Project Grant Awarded Last action

Award ID
R43DK096602
Recipient
Awarding agency
Obligated
$582,763

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Place of performance
Danbury, CT 06810, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $143,533
Amendment $150,000
Amendment $139,230
Original award $150,000

Quick answers

Who received award R43DK096602?

R43DK096602 was awarded to Albireo Pharma, Inc. by National Institutes of Health (Department of Health and Human Services) on September 19, 2012.

How much is award R43DK096602 worth?

$582,763 has been obligated on R43DK096602.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award